Aligos Therapeutics logo

Aligos Therapeutics

South San Francisco, CA

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.

aligos.com

Company Details

Founded

2018

Employees

Between 83 - 500 employees

Raised

$317,000,000

Headquarters Location

South San Francisco, CA

Public

Yes

Acquired

No

CEO

Lawrence BlattLawrence Blatt

Founders

Lawrence Blatt
Lawrence Blatt

Company Collections

These are collections Aligos Therapeutics is a part of. Click on the collection name to view similar companies.

Aligos Therapeutics' Tech Stack